Arcturus Therapeutics (ARCT) is scheduled to report Q1 earnings on May 11, 2026. Analysts estimate EPS of $-1.06 and quarterly revenue of $7.48M.

In the most recent quarter (Q4), Arcturus Therapeutics reported EPS of $-1.03, missing estimates of $-0.82 by 0.26%. Revenue came in at $7.20M, missing the estimate of $14.34M by 0.50%.

Over the last 4 quarters, Arcturus Therapeutics has averaged an EPS surprise of 0.48% and a revenue surprise of 0.34%.